Recent research identifies a significant link between uric acid osteoporosis risk. Scientists analyzed data from the 2015-2020 NHANES and conducted Mendelian randomization to understand how serum uric acid (SUA) influences bone health. Consequently, they found that higher SUA levels correlate with a reduced risk of osteoporosis.

The cross-sectional study included 6,020 participants. Individuals in the highest SUA quartiles showed a 49% lower risk compared to those in the lowest quartile. Furthermore, restricted cubic spline analysis revealed an L-shaped relationship. The study pinpointed a turning point at approximately 5.3 mg/dL. This suggests that maintaining moderate SUA levels might provide a protective effect against bone loss.

Clinical Implications of Uric Acid Osteoporosis Risk

Subgroup analysis indicated that sex, race, and diabetes status are essential modifiers. Additionally, the Mendelian randomization analysis explored whether these findings represent a causal relationship. Although SUA is often associated with gout, its antioxidant properties may actually benefit bone metabolism. Therefore, physicians should consider these nuances when managing patients with metabolic disorders. Moreover, the study highlights the need for balanced clinical strategies regarding urate-lowering therapies.

Frequently Asked Questions

How does uric acid affect bone density?

Serum uric acid may act as an antioxidant in the blood. This helps protect bone mineral density and potentially reduces the risk of osteoporosis.

What uric acid level is associated with lower osteoporosis risk?

The study identified an L-shaped association. It showed a significant turning point around 5.3 mg/dL, where the risk of osteoporosis began to decrease significantly.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Liu QP et al. Association between serum uric acid levels and osteoporosis risk: evidence from a cross-sectional study and Mendelian randomization analysis. Clin Rheumatol. 2026 Feb 14. doi: 10.1007/s10067-026-07986-3. PMID: 41689734.

Wang H et al. Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose-Response Meta-Analysis. Int J Rheum Dis. 2025 Jan 15. doi: 10.1111/1756-185X.70013. PMID: 39744825.

Song S et al. Value of serum uric acid in a risk prediction model for postmenopausal osteoporosis. Front Endocrinol (Lausanne). 2025 Aug 09;16:1434602. doi: 10.3389/fendo.2025.1434602.